N@N

Eventide Asset Management: Finny Kuruvilla, MD, PhD of Eventide Asset Management Named One of the Top Emerging Mutual Fund Mana

^{Published on 2009-09-14 11:48:50 - Market Wire}
 

BOSTON, MA--(Marketwire - September 14, 2009) - Finny Kuruvilla, MD, PhD was named as one of the top performing emerging mutual fund managers for new mutual funds that have been in existence for less than 1.5 years according to Fund Mojo, a financial network that provides financial intelligence, data collection and analysis to financial advisors and investors. Selection criteria involved analyzing fund managers who have outperformed category averages since their inception.

Dr. Kuruvilla has managed the Eventide Gilead Fund (NASDAQ: [ ETGLX ]) portfolio since its inception in July, 2008. He possesses a diverse background in quantitative methods, with applications focused on innovations in science, engineering, and medicine. He holds an MD from Harvard Medical School, a PhD in Chemistry and Chemical Biology from Harvard University, a master's degree in Electrical Engineering and Computer Science from MIT, and a bachelor's degree from Caltech in Chemistry. His residency and fellowship were completed at the Brigham & Women's Hospital and Children's Hospital, Boston.

Dr. Kuruvilla is a managing partner with Eventide Asset Management, LLC. Eventide Asset Management offers investment advisory services for both individual and institutional investors and aims to invest in companies that operate with integrity and create value for customer, shareholder, and society. Eventide appeals to both the socially responsible and biblically responsible investor.

Investment return and principal value will fluctuate with changing market conditions so that when redeemed shares may be worth more or less than the original costs. Please consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus containing this and other important information please download the prospectus from [ http://www.eventidefunds.com ] or call the fund at 877.453.7877. Please read the prospectus carefully before investing or sending money. Matrix Capital Group, Inc., New York, NY distributor.